Simon E. G.
Ustekinumab: a novel therapeutic option in Crohn's disease
E. G., Simon; S., Samuel; S., Ghosh; G. W., Moran
Citation
E. G., S., S., S., S., G., & G. W., M. (2016). Ustekinumab: a novel therapeutic option in Crohn's disease. Expert Opinion on Biological Therapy, 16(8), 1065-1074. doi:10.1080/14712598.2016.1205582
| Journal Article Type | Article |
|---|---|
| Acceptance Date | Jun 20, 2016 |
| Online Publication Date | Jul 6, 2016 |
| Publication Date | Jun 24, 2016 |
| Deposit Date | Dec 13, 2018 |
| Print ISSN | 1471-2598 |
| Electronic ISSN | 1744-7682 |
| Publisher | Taylor & Francis |
| Peer Reviewed | Peer Reviewed |
| Volume | 16 |
| Issue | 8 |
| Pages | 1065-1074 |
| DOI | https://doi.org/10.1080/14712598.2016.1205582 |
| Keywords | Anti-TNF agents; biologic therapy; Crohn’s disease; ustekinumab |
| Public URL | https://nottingham-repository.worktribe.com/output/1413174 |
| Publisher URL | https://www.tandfonline.com/doi/full/10.1080/14712598.2016.1205582 |
You might also like
BSG 2024 IBD guidelines protocol (standard operating procedures)
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search